BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

4:43 PM
 | 
Jun 24, 2010
 |  BC Extra  |  Company News

Pfizer suspends tanezumab for OA

Pfizer Inc. (NYSE:PFE) suspended its osteoarthritis (OA) program for tanezumab after FDA placed it on clinical hold due to a "small number" of cases of worsening OA leading to joint replacement in tanezumab-treated patients. Pfizer...

Read the full 164 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >